Moreover, it has been reported that the expression of checkpoint inhibitors, such as PD-1 and PD-L1, by Bregs in hepatocellular carcinoma (HCC) samples leads to the suppression of anti-tumor activity [38] (Figure 1). The gene discussed is CD274; the disease is hepatocellular carcinoma.